News Corporate
Werfen Annual Report 2019 released
May 7, 2020
Discover more about: Who we are; what we do; how we are improving laboratory medicine worldwide and get an update on our business related activities, financial performance, corporate governance, citizenship, talent and much more by clicking here.
Share:
NEWS
Latest News
Autoimmunity
September 23, 2026
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
...
Corporate
August 31, 2026 - Bedford, Massachusetts
WERFEN RECEIVES 2026 IMV ServiceTrak™ AWARDS FOR BEST CUSTOMER SATISFACTION, SYSTEM PERFORMANCE AND SERVICE IN COAGULATION
...
Acute Care
May 5, 2026 - Bedford, MA
The risks of in vitro hemolysis and the importance of early detection in critical care medicine — an ICU clinician’s perspective
...
Acute Care
December 11, 2025 - Bedford, MA
WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS
...
